Literature DB >> 23358883

Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.

Philippe Kastner1, Arnaud Dupuis, Marie-Pierre Gaub, Raoul Herbrecht, Patrick Lutz, Susan Chan.   

Abstract

The Ikaros transcription factor is crucial for many aspects of hematopoiesis. Loss of function mutations in IKZF1, the gene encoding Ikaros, have been implicated in adult and pediatric B cell acute lymphoblastic leukemia (B-ALL). These mutations result in haploinsufficiency of the Ikaros gene in approximately half of the cases. The remaining cases contain more severe or compound mutations that lead to the generation of dominant-negative proteins or complete loss of function. All IKZF1 mutations are associated with a poor prognosis. Here we review the current genetic, clinical and mechanistic evidence for the role of Ikaros as a tumor suppressor in B-ALL.

Entities:  

Keywords:  B cell leukemia; Ikaros; tumor suppressor

Year:  2013        PMID: 23358883      PMCID: PMC3555193     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  74 in total

1.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

Review 2.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

3.  IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

Authors:  R P Kuiper; E Waanders; V H J van der Velden; S V van Reijmersdal; R Venkatachalam; B Scheijen; E Sonneveld; J J M van Dongen; A J P Veerman; F N van Leeuwen; A Geurts van Kessel; P M Hoogerbrugge
Journal:  Leukemia       Date:  2010-05-06       Impact factor: 11.528

4.  Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia.

Authors:  C Virely; S Moulin; C Cobaleda; C Lasgi; A Alberdi; J Soulier; F Sigaux; S Chan; P Kastner; J Ghysdael
Journal:  Leukemia       Date:  2010-04-15       Impact factor: 11.528

5.  Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  S Krentz; J Hof; A Mendioroz; R Vaggopoulou; P Dörge; C Lottaz; J C Engelmann; T W L Groeneveld; G Körner; K Seeger; C Hagemeier; G Henze; C Eckert; A von Stackelberg; R Kirschner-Schwabe
Journal:  Leukemia       Date:  2012-06-13       Impact factor: 11.528

6.  Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

Authors:  Richard C Harvey; Charles G Mullighan; I-Ming Chen; Walker Wharton; Fady M Mikhail; Andrew J Carroll; Huining Kang; Wei Liu; Kevin K Dobbin; Malcolm A Smith; William L Carroll; Meenakshi Devidas; W Paul Bowman; Bruce M Camitta; Gregory H Reaman; Stephen P Hunger; James R Downing; Cheryl L Willman
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

7.  LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes.

Authors:  K Lo; N R Landau; S T Smale
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.

Authors:  N A Heerema; J B Nachman; H N Sather; M K La; R Hutchinson; B J Lange; B Bostrom; P G Steinherz; P S Gaynon; F M Uckun
Journal:  Leukemia       Date:  2004-05       Impact factor: 11.528

9.  High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

Authors:  R P Kuiper; E F P M Schoenmakers; S V van Reijmersdal; J Y Hehir-Kwa; A Geurts van Kessel; F N van Leeuwen; P M Hoogerbrugge
Journal:  Leukemia       Date:  2007-04-19       Impact factor: 11.528

10.  Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

Authors:  Ilaria Iacobucci; Annalisa Lonetti; Francesca Messa; Daniela Cilloni; Francesca Arruga; Emanuela Ottaviani; Stefania Paolini; Cristina Papayannidis; Pier Paolo Piccaluga; Panagiota Giannoulia; Simona Soverini; Marilina Amabile; Angela Poerio; Giuseppe Saglio; Fabrizio Pane; Giorgio Berton; Anna Baruzzi; Antonella Vitale; Sabina Chiaretti; Giovanni Perini; Robin Foà; Michele Baccarani; Giovanni Martinelli
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

View more
  30 in total

1.  Ikaros' suspended flight in the thymus.

Authors:  Naomi Taylor; Valérie S Zimmermann
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

2.  Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.

Authors:  T Lana; P de Lorenzo; S Bresolin; I Bronzini; M L den Boer; H Cavé; E Froňková; M Stanulla; M Zaliova; C J Harrison; H de Groot; M G Valsecchi; A Biondi; G Basso; G Cazzaniga; G te Kronnie
Journal:  Leukemia       Date:  2015-03-17       Impact factor: 11.528

3.  Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

Authors:  H S Kuehn; B Boisson; M E Conley; S D Rosenzweig; C Cunningham-Rundles; J Reichenbach; A Stray-Pedersen; E W Gelfand; P Maffucci; K R Pierce; J K Abbott; K V Voelkerding; S T South; N H Augustine; J S Bush; W K Dolen; B B Wray; Y Itan; A Cobat; H S Sorte; S Ganesan; S Prader; T B Martins; M G Lawrence; J S Orange; K R Calvo; J E Niemela; J-L Casanova; T A Fleisher; H R Hill; A Kumánovics
Journal:  N Engl J Med       Date:  2016-03-17       Impact factor: 91.245

Review 4.  The role of zinc and its compounds in leukemia.

Authors:  Alexey P Orlov; Marina A Orlova; Tatiana P Trofimova; Stepan N Kalmykov; Dmitry A Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2018-02-28       Impact factor: 3.358

5.  Transcriptional regulation of the Ikzf1 locus.

Authors:  Toshimi Yoshida; Esther Landhuis; Marei Dose; Idit Hazan; Jiangwen Zhang; Taku Naito; Audrey F Jackson; Jeffrey Wu; Elizabeth A Perotti; Christoph Kaufmann; Fotini Gounari; Bruce A Morgan; Katia Georgopoulos
Journal:  Blood       Date:  2013-09-03       Impact factor: 22.113

6.  Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia.

Authors:  Sanjive Qazi; Fatih M Uckun
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

7.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 8.  Ikaros fingers on lymphocyte differentiation.

Authors:  Toshimi Yoshida; Katia Georgopoulos
Journal:  Int J Hematol       Date:  2014-08-02       Impact factor: 2.490

9.  Absence of Genomic Ikaros/IKZF1 Deletions in Pediatric B-Precursor Acute Lymphoblastic Leukemia.

Authors:  Sanjive Qazi; Hong Ma; Fatih M Uckun
Journal:  Int J Mol Med Sci       Date:  2013-07-29

Review 10.  IKAROS Family Zinc Finger 1-Associated Diseases in Primary Immunodeficiency Patients.

Authors:  Cristiane J Nunes-Santos; Hye Sun Kuehn; Sergio D Rosenzweig
Journal:  Immunol Allergy Clin North Am       Date:  2020-08       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.